Netia Medical Technologies
Netia, a Nebraska-based medical firm, licenses its patented RNAi drug development platform for cost-effective, faster, and versatile pharmaceutical solutions.
Founded
1989Netia, a Nebraska-based medical firm, licenses its patented RNAi drug development platform for cost-effective, faster, and versatile pharmaceutical solutions.
Netia Medical Technologies, based in Omaha, Nebraska, is dedicated to revolutionizing drug development through its innovative RNAi platform. The company's core mission is to provide cost-effective, faster, and versatile pharmaceutical solutions by licensing its patented single-strand RNAi drug development technology. This platform significantly reduces the time and cost required to bring new drugs to market, making it a valuable asset for pharmaceutical companies and academic groups focused on translational research.
Netia's technology is supported by six patent filings and has the potential to address 'undruggable' targets, thereby expanding the scope of treatable conditions. The company has garnered attention for its ability to cut conventional drug development costs by more than half and reduce the time to market by three years. This impact positions Netia as a transformative player in the pharmaceutical industry, driving advancements in medical research and therapeutic solutions.
Companies similar to Netia Medical Technologies include Net Medical Xpress Solutions, Neumedics, Nuveta and Nerx Biosciences.
Netia Medical Technologies was founded in 1989.
Netia Medical Technologies' headquarters is located in Omaha, NE, US.
Netia Medical Technologies' most recent funding round was for $800k (USD) in November 2010.
As of Nov 23, 2010, Netia Medical Technologies has raised a total of $800k (USD).
Netia Medical Technologies has 5 employees as of Feb 4, 2024.
Nuveta
nuveta.com
